Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrointestinal Microbiome | 17 | 2023 | 160 | 1.960 |
Why?
|
| Microbiota | 11 | 2022 | 100 | 0.910 |
Why?
|
| Oligosaccharides | 4 | 2021 | 17 | 0.650 |
Why?
|
| Parkinson Disease | 6 | 2023 | 666 | 0.590 |
Why?
|
| Feces | 9 | 2023 | 102 | 0.540 |
Why?
|
| Circadian Rhythm | 4 | 2022 | 236 | 0.540 |
Why?
|
| Food Hypersensitivity | 3 | 2021 | 45 | 0.470 |
Why?
|
| Inflammation | 3 | 2020 | 275 | 0.410 |
Why?
|
| Bacteria | 5 | 2022 | 73 | 0.410 |
Why?
|
| Colon, Sigmoid | 3 | 2017 | 16 | 0.390 |
Why?
|
| Sinusitis | 3 | 2020 | 161 | 0.390 |
Why?
|
| Prebiotics | 3 | 2023 | 24 | 0.370 |
Why?
|
| HIV Infections | 3 | 2022 | 466 | 0.350 |
Why?
|
| Intestines | 3 | 2021 | 84 | 0.350 |
Why?
|
| Colon | 6 | 2023 | 122 | 0.340 |
Why?
|
| Animals | 14 | 2023 | 3602 | 0.330 |
Why?
|
| Saliva | 2 | 2022 | 52 | 0.330 |
Why?
|
| Eating | 2 | 2021 | 57 | 0.320 |
Why?
|
| Multiple System Atrophy | 2 | 2022 | 32 | 0.320 |
Why?
|
| Disease Models, Animal | 6 | 2023 | 590 | 0.310 |
Why?
|
| Nose | 2 | 2020 | 38 | 0.300 |
Why?
|
| HIV-1 | 2 | 2022 | 226 | 0.280 |
Why?
|
| Dysbiosis | 3 | 2018 | 46 | 0.280 |
Why?
|
| Mice | 9 | 2023 | 1416 | 0.270 |
Why?
|
| Milk, Human | 2 | 2019 | 152 | 0.250 |
Why?
|
| Mice, Inbred C57BL | 7 | 2023 | 443 | 0.240 |
Why?
|
| Colitis | 2 | 2023 | 31 | 0.240 |
Why?
|
| Immune System | 2 | 2021 | 15 | 0.230 |
Why?
|
| Milk | 2 | 2021 | 14 | 0.220 |
Why?
|
| Humans | 24 | 2023 | 26976 | 0.220 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2023 | 18 | 0.210 |
Why?
|
| STAT3 Transcription Factor | 1 | 2023 | 14 | 0.200 |
Why?
|
| Female | 16 | 2022 | 15196 | 0.190 |
Why?
|
| Biodiversity | 2 | 2019 | 35 | 0.190 |
Why?
|
| Shift Work Schedule | 1 | 2022 | 9 | 0.190 |
Why?
|
| Mouth | 1 | 2022 | 14 | 0.190 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2021 | 23 | 0.190 |
Why?
|
| Astrocytes | 1 | 2023 | 147 | 0.190 |
Why?
|
| Dietary Supplements | 1 | 2021 | 64 | 0.190 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2018 | 34 | 0.180 |
Why?
|
| Male | 15 | 2022 | 14756 | 0.180 |
Why?
|
| Anti-HIV Agents | 1 | 2022 | 68 | 0.180 |
Why?
|
| Animal Husbandry | 1 | 2020 | 8 | 0.170 |
Why?
|
| Macaca mulatta | 1 | 2020 | 61 | 0.170 |
Why?
|
| Weight Gain | 1 | 2020 | 64 | 0.170 |
Why?
|
| Trisaccharides | 1 | 2019 | 3 | 0.160 |
Why?
|
| Influenza Vaccines | 1 | 2019 | 13 | 0.160 |
Why?
|
| Colonic Polyps | 1 | 2019 | 31 | 0.160 |
Why?
|
| Microglia | 1 | 2020 | 142 | 0.160 |
Why?
|
| Osteolysis | 1 | 2020 | 137 | 0.160 |
Why?
|
| Specimen Handling | 1 | 2019 | 44 | 0.160 |
Why?
|
| Mucous Membrane | 1 | 2019 | 30 | 0.160 |
Why?
|
| Alcohol Drinking | 1 | 2019 | 76 | 0.150 |
Why?
|
| Prostheses and Implants | 1 | 2020 | 153 | 0.150 |
Why?
|
| Sleep Wake Disorders | 1 | 2020 | 119 | 0.150 |
Why?
|
| Rotenone | 1 | 2018 | 8 | 0.150 |
Why?
|
| Feeding Behavior | 1 | 2019 | 86 | 0.150 |
Why?
|
| Influenza, Human | 1 | 2019 | 47 | 0.150 |
Why?
|
| Gastrointestinal Diseases | 1 | 2018 | 30 | 0.150 |
Why?
|
| Tea | 1 | 2018 | 6 | 0.150 |
Why?
|
| Mouth Mucosa | 1 | 2018 | 13 | 0.150 |
Why?
|
| Intestinal Mucosa | 2 | 2019 | 158 | 0.150 |
Why?
|
| Mouth Neoplasms | 1 | 2018 | 22 | 0.140 |
Why?
|
| Rhinitis, Allergic | 1 | 2018 | 14 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2018 | 22 | 0.140 |
Why?
|
| Prosthesis-Related Infections | 1 | 2020 | 186 | 0.140 |
Why?
|
| Herpesvirus 2, Human | 1 | 2017 | 7 | 0.140 |
Why?
|
| Ulcer | 1 | 2017 | 7 | 0.140 |
Why?
|
| Herpes Genitalis | 1 | 2017 | 6 | 0.140 |
Why?
|
| Obesity | 1 | 2020 | 304 | 0.140 |
Why?
|
| MicroRNAs | 1 | 2018 | 47 | 0.140 |
Why?
|
| Antioxidants | 1 | 2018 | 66 | 0.140 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2017 | 7 | 0.140 |
Why?
|
| Vaginosis, Bacterial | 1 | 2017 | 29 | 0.140 |
Why?
|
| Dermatitis, Atopic | 1 | 2017 | 14 | 0.140 |
Why?
|
| DNA | 1 | 2017 | 102 | 0.140 |
Why?
|
| Dietary Fiber | 1 | 2017 | 28 | 0.140 |
Why?
|
| Parkinsonian Disorders | 1 | 2020 | 223 | 0.140 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 411 | 0.140 |
Why?
|
| Fatty Acids, Volatile | 3 | 2023 | 33 | 0.130 |
Why?
|
| Butyrates | 3 | 2022 | 18 | 0.130 |
Why?
|
| Asthma | 1 | 2018 | 148 | 0.130 |
Why?
|
| Rhinitis | 1 | 2018 | 142 | 0.130 |
Why?
|
| Circadian Clocks | 1 | 2016 | 22 | 0.120 |
Why?
|
| Brain | 2 | 2021 | 1647 | 0.120 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2019 | 56 | 0.110 |
Why?
|
| alpha-Synuclein | 1 | 2015 | 124 | 0.110 |
Why?
|
| Chronic Disease | 3 | 2020 | 417 | 0.100 |
Why?
|
| Pilot Projects | 3 | 2019 | 411 | 0.100 |
Why?
|
| Adult | 6 | 2022 | 7877 | 0.090 |
Why?
|
| Cecum | 2 | 2019 | 14 | 0.080 |
Why?
|
| Carcinogenesis | 2 | 2019 | 25 | 0.080 |
Why?
|
| Immunity, Mucosal | 2 | 2019 | 14 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2020 | 588 | 0.070 |
Why?
|
| Young Adult | 3 | 2018 | 2016 | 0.070 |
Why?
|
| Ethanol | 2 | 2019 | 87 | 0.070 |
Why?
|
| Time Factors | 2 | 2020 | 1431 | 0.060 |
Why?
|
| Adolescent | 2 | 2022 | 2147 | 0.050 |
Why?
|
| Middle Aged | 4 | 2018 | 9017 | 0.050 |
Why?
|
| Dextran Sulfate | 1 | 2023 | 9 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2023 | 124 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2023 | 135 | 0.050 |
Why?
|
| Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination | 1 | 2022 | 4 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2023 | 523 | 0.050 |
Why?
|
| Proof of Concept Study | 1 | 2022 | 12 | 0.050 |
Why?
|
| Mitochondria | 1 | 2022 | 66 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 102 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2021 | 57 | 0.050 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 42 | 0.050 |
Why?
|
| Precision Medicine | 1 | 2021 | 28 | 0.050 |
Why?
|
| Pasteurization | 1 | 2021 | 3 | 0.050 |
Why?
|
| Genomics | 1 | 2021 | 64 | 0.040 |
Why?
|
| Macrophages | 1 | 2022 | 113 | 0.040 |
Why?
|
| Leptin | 1 | 2020 | 21 | 0.040 |
Why?
|
| Cadherins | 1 | 2020 | 34 | 0.040 |
Why?
|
| Life Style | 1 | 2022 | 178 | 0.040 |
Why?
|
| Pregnancy | 1 | 2021 | 334 | 0.040 |
Why?
|
| Anilides | 1 | 2020 | 7 | 0.040 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2020 | 20 | 0.040 |
Why?
|
| Neurotoxins | 1 | 2020 | 15 | 0.040 |
Why?
|
| Food | 1 | 2020 | 37 | 0.040 |
Why?
|
| Glucose | 1 | 2020 | 55 | 0.040 |
Why?
|
| Random Allocation | 1 | 2020 | 122 | 0.040 |
Why?
|
| DNA, Ribosomal | 1 | 2020 | 5 | 0.040 |
Why?
|
| Pyridines | 1 | 2020 | 33 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2020 | 46 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2020 | 41 | 0.040 |
Why?
|
| Insulin | 1 | 2020 | 91 | 0.040 |
Why?
|
| Proteobacteria | 1 | 2019 | 2 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2020 | 108 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2020 | 88 | 0.040 |
Why?
|
| Mice, Inbred C3H | 1 | 2019 | 20 | 0.040 |
Why?
|
| Diet Therapy | 1 | 2019 | 11 | 0.040 |
Why?
|
| Period Circadian Proteins | 1 | 2019 | 15 | 0.040 |
Why?
|
| Lactobacillus | 1 | 2019 | 20 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2019 | 25 | 0.040 |
Why?
|
| Photoperiod | 1 | 2019 | 31 | 0.040 |
Why?
|
| Freezing | 1 | 2019 | 14 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2019 | 59 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2020 | 190 | 0.040 |
Why?
|
| Galactose | 1 | 2019 | 5 | 0.040 |
Why?
|
| Fructose | 1 | 2019 | 6 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2019 | 76 | 0.040 |
Why?
|
| Th1 Cells | 1 | 2019 | 28 | 0.040 |
Why?
|
| Vaccination | 1 | 2019 | 35 | 0.040 |
Why?
|
| CD3 Complex | 1 | 2018 | 4 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 55 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2019 | 32 | 0.040 |
Why?
|
| Rats | 1 | 2020 | 637 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 224 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2019 | 80 | 0.040 |
Why?
|
| Gingiva | 1 | 2018 | 3 | 0.040 |
Why?
|
| Streptococcus | 1 | 2018 | 3 | 0.040 |
Why?
|
| Catechin | 1 | 2018 | 4 | 0.040 |
Why?
|
| Staphylococcus | 1 | 2018 | 9 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 70 | 0.040 |
Why?
|
| Epithelium | 1 | 2018 | 28 | 0.040 |
Why?
|
| Smokers | 1 | 2018 | 12 | 0.040 |
Why?
|
| Protective Agents | 1 | 2018 | 10 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2018 | 22 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 30 | 0.040 |
Why?
|
| Genitalia | 1 | 2017 | 3 | 0.040 |
Why?
|
| Kenya | 1 | 2017 | 10 | 0.040 |
Why?
|
| Pancreas | 1 | 2018 | 33 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 670 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2018 | 310 | 0.040 |
Why?
|
| Biomarkers | 1 | 2020 | 558 | 0.040 |
Why?
|
| Myxovirus Resistance Proteins | 1 | 2017 | 3 | 0.040 |
Why?
|
| Interferon Type I | 1 | 2017 | 11 | 0.030 |
Why?
|
| Ubiquitins | 1 | 2017 | 9 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 118 | 0.030 |
Why?
|
| South Africa | 1 | 2017 | 13 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 124 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2017 | 41 | 0.030 |
Why?
|
| Viral Load | 1 | 2017 | 75 | 0.030 |
Why?
|
| Quality of Life | 1 | 2022 | 622 | 0.030 |
Why?
|
| Sleep | 1 | 2020 | 324 | 0.030 |
Why?
|
| Homeostasis | 1 | 2017 | 69 | 0.030 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2017 | 13 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 143 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2016 | 23 | 0.030 |
Why?
|
| CLOCK Proteins | 1 | 2016 | 16 | 0.030 |
Why?
|
| Cytokines | 1 | 2017 | 235 | 0.030 |
Why?
|
| Protein Folding | 1 | 2015 | 19 | 0.030 |
Why?
|
| Infant | 1 | 2017 | 506 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 1106 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2017 | 609 | 0.030 |
Why?
|
| Child | 1 | 2018 | 1240 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2019 | 1900 | 0.030 |
Why?
|
| Cognition | 1 | 2020 | 1333 | 0.020 |
Why?
|
| Aged | 1 | 2015 | 9068 | 0.010 |
Why?
|